Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma

NCT00472966 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Melasma

Interventions

DRUG: Fluocinolone acetonide 0.1%/hydroquinone 4%/tretinoin 0.05% Cream in sequence with glycolic acid peels

Sponsor

Galderma R&D